Part of my work involves reviewing documentation against ISO compliance requirements. What I've found is that the same instinct that makes you a careful document reviewer — asking "where's the proof of this claim?" and "who authorised this?" — is exactly what protects you as a clinical trial participant. You don't need technical knowledge. You need to ask the right questions and notice when the answers are evasive.
Clinical research has a strong regulatory framework behind it — IRB oversight, FDA requirements, international standards. But the framework isn't perfect, and it doesn't cover every study that uses the word "trial" to describe itself. Knowing what well-run research looks like helps you recognize when something doesn't fit.
No IRB registration or ethics approval
Any legitimate clinical trial on human participants must be approved by an Institutional Review Board (IRB) or equivalent ethics committee. The consent form should reference this approval and include the committee's contact information. If someone can't tell you who approved the ethics of their study, or if the consent form doesn't mention IRB approval, stop.
You can also verify trial registration independently: US trials should be registered at ClinicalTrials.gov. European trials appear in EUCTR. If you can't find the trial in a public registry, ask why. Unregistered studies are not necessarily fraudulent, but absence from the registry is a question worth asking.
Pressure to decide quickly
Legitimate trials do not pressure you. You have as much time as you need to read the consent form, ask questions, and consult your doctor. If a recruiter tells you that slots are filling fast, that you need to commit today, or that you'll lose your place if you don't decide now — that's a pressure tactic. Good research teams don't use those.
Unusually high compensation
Most trials pay modestly for time and inconvenience. Very high payment amounts are a red flag because they can indicate that the trial is trying to financially incentivize people to overlook risks they'd otherwise decline. IRBs are supposed to catch this, but it slips through sometimes. If you're being offered substantially more than typical compensation (hundreds of euros per visit for what sounds like a simple study), ask more questions.
Guarantees of benefit
A legitimate trial cannot guarantee that you'll benefit from participation. Anyone who tells you this treatment will definitely help you is not being truthful with you — which is, by definition, a problem in a clinical research context. Research exists precisely because we don't know yet whether it works.
Vague or missing consent documentation
The informed consent document is a legal requirement. It must describe the study purpose, procedures, risks, benefits, alternatives, and your rights. If someone presents you with a single-page form, refuses to give you the document in advance, or discourages you from reading it carefully, those are serious problems.
They discourage you from consulting your doctor
Any trial recruiter who tells you there's no need to talk to your own doctor before enrolling is either mistaken or doesn't want external scrutiny. Your own doctor knows your full medical history. Their input is valuable. A good trial team will welcome your doctor's involvement — or at minimum not discourage it.
When in doubt, check
Contact the IRB or ethics committee listed in the consent form and verify the study is approved. Search the trial registry. Ask your own doctor to review the protocol. None of these steps are insulting to a legitimate research team — they're exactly what a careful patient is supposed to do.
Medical Disclaimer: This guide describes general warning signs based on regulatory standards. If you have specific concerns about a trial, report them to the IRB listed in your consent form or the relevant national medicines authority.